STAT3 and familial pancreatic carcinoma: Inhibiting STAT3 can reduce noradrenaline-induced expression of NGF, matrix metallopeptidase (MMP) 2, and MMP 9, as well as diminish the migratory and invasive capabilities of pancreatic cancer cells.